Skip to main content

Banzel Side Effects

Generic name: rufinamide

Medically reviewed by Philip Thornton, DipPharm. Last updated on Nov 2, 2023.

Note: This document contains side effect information about rufinamide. Some dosage forms listed on this page may not apply to the brand name Banzel.

Applies to rufinamide: oral suspension, oral tablet.

Serious side effects of Banzel

Along with its needed effects, rufinamide (the active ingredient contained in Banzel) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking rufinamide:

More common

Less common

Rare

Other side effects of Banzel

Some side effects of rufinamide may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Rare

For Healthcare Professionals

Applies to rufinamide: oral suspension, oral tablet.

Nervous system

Very common (10% or more): Somnolence, headache, dizziness

Common (1% to 10%): Status epilepticus, convulsion, abnormal coordination, nystagmus, psychomotor hyperactivity, tremor[Ref]

General

The most commonly reported adverse reactions overall were headache, dizziness, fatigue, and somnolence.[Ref]

Gastrointestinal

Very common (10% or more): Nausea, vomiting

Common (1% to 10%): Upper abdominal pain, constipation, dyspepsia, diarrhea[Ref]

Ocular

Common (1% to 10%): Diplopia, blurred vision, nystagmus[Ref]

Psychiatric

Common (1% to 10%): Anxiety, insomnia

Frequency not reported: Suicidal behavior and ideation[Ref]

Musculoskeletal

Common (1% to 10%): Back pain[Ref]

Hematologic

Very common (10% or more): Anemia

Uncommon (0.1% to 1%): Lymphadenopathy, leukopenia, neutropenia, iron deficiency anemia, thrombocytopenia[Ref]

Metabolic

Common (1% to 10%): Anorexia, eating disorder, decreased appetite, weight loss[Ref]

Cardiovascular

Uncommon (0.1% to 1%): Right bundle branch block, first degree atrioventricular block

Frequency not reported: QT shortening[Ref]

Dermatologic

Common (1% to 10%): Rash, acne

Postmarketing reports: Stevens-Johnson syndrome and other serious skin rashes with mucosal involvement[Ref]

Genitourinary

Common (1% to 10%): Oligomenorrhea[Ref]

Hepatic

Uncommon (0.1% to 1%): Hepatic enzymes increased[Ref]

Hypersensitivity

Frequency not reported: Multi-organ sensitivity reactions (DRESS)

Postmarketing reports: DRESS[Ref]

Immunologic

Common (1% to 10%): Pneumonia, influenza, nasopharyngitis, ear infection sinusitis, rhinitis[Ref]

Other

Very common (10% or more): Fatigue

Common (1% to 10%): Gait disturbance

Frequency not reported: Head injury, contusion[Ref]

Respiratory

Common (1% to 10%): Epistaxis[Ref]

Frequently asked questions

References

1. Cerner Multum, Inc. UK Summary of Product Characteristics.

2. Product Information. Banzel (rufinamide). Eisai Inc. 2008.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.